| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.77.6.1238 |
| P8608 | Fatcat ID | release_2iovc4hy5faldd4dz2klpawkgq |
| P698 | PubMed publication ID | 2967127 |
| P2093 | author name string | Jürgens G | |
| Beck GJ | |||
| O'Neil J | |||
| Kramer J | |||
| Hoff HF | |||
| Skibinski CI | |||
| Lytle B | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | LPA | Q18028636 |
| coronary artery bypass surgery | Q186020 | ||
| stenosis | Q2343082 | ||
| P304 | page(s) | 1238-1244 | |
| P577 | publication date | 1988-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients | |
| P478 | volume | 77 |
| Q57419867 | Antibodies to cardiolipin may increase the risk of failure of peripheral vein bypasses |
| Q24294266 | Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms |
| Q47272541 | Apolipoprotein(a) size polymorphism in young adults with ischemic stroke |
| Q72548842 | Arterial thrombosis: putative role of lipoprotein(a) |
| Q47435950 | Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery |
| Q51052093 | Automated latex nephelometric immunoassay for the measurement of serum lipoprotein (a). |
| Q33544622 | Biochemical risk factors and patient's outcome: the case of lipoprotein(a). |
| Q44235869 | Blood Rheology and Cardiovascular Risk Factors in Type 1 Diabetes: Relationship with Microalbuminuria |
| Q74096159 | Coronary revascularization in women |
| Q37215596 | Coronary vein graft disease: pathogenesis and prevention |
| Q50117114 | Correlates of vascular access occlusion in hemodialysis |
| Q74598318 | Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease |
| Q45083065 | Determination of Lp(a) and APO(a) in an Italian population. |
| Q40725852 | Disturbances of lipid metabolism in children with chronic renal failure |
| Q47928548 | Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events? |
| Q50930387 | Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD. |
| Q33719966 | Effects of exercise on lipoprotein(a). |
| Q46653684 | Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery |
| Q44975283 | Elevated levels of low-density lipoprotein cholesterol, homocysteine, and lipoprotein(a) are associated with the occurrence of symptomatic bypass graft disease 1 year following coronary artery bypass graft surgery |
| Q46951870 | Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke |
| Q39439221 | Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? |
| Q71858695 | Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques |
| Q35224510 | Fibrin, Lipoprotein(a), Plasmin Interactions: A Model Linking Thrombosis and Atherogenesisa |
| Q41517328 | Gonadal hormone substitutes: effects on the cardiovascular system |
| Q71244214 | High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease |
| Q37271062 | Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism |
| Q36233246 | Hypercoagulability in Vascular Surgery Patients |
| Q24557502 | Hypothesis: lipoprotein(a) is a surrogate for ascorbate |
| Q35716459 | Influence of smoking and plasma factors on patency of femoropopliteal vein grafts |
| Q40845127 | Infrainguinal vein graft stenosis |
| Q46436558 | Is lipoprotein (a)-apheresis useful? |
| Q74233396 | Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease |
| Q45169038 | Limits of lipoprotein Lp(a) detection by polyacrylamide gel electrophoresis in discontinuous gradient |
| Q51597611 | Lipid parameters including Lp(a) in hemodialysis patients. |
| Q30242031 | Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology |
| Q46861418 | Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase |
| Q42800361 | Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin |
| Q41695853 | Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis |
| Q40964818 | Lipoprotein (a). |
| Q40757462 | Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy |
| Q77700147 | Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation |
| Q36814085 | Lipoprotein(a) and its role in occlusive vascular disease. |
| Q43654637 | Lipoprotein(a) and its role in occlusive vascular disease. |
| Q21284797 | Lipoprotein(a) in cardiovascular diseases |
| Q73662507 | Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm |
| Q44096359 | Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis |
| Q40568220 | Lipoprotein(a): new insights into an atherogenic lipoprotein |
| Q38297789 | Lipoprotein(a): searching for a function |
| Q37343671 | Metabolic syndrome and cardiovascular disease in South Asians |
| Q40880294 | Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells |
| Q40476385 | Pathophysiology of vein graft failure: A review |
| Q72809756 | Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival |
| Q70186517 | Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast |
| Q52094145 | Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. |
| Q69368751 | Raised serum lipoprotein during treatment with lovastatin |
| Q73318670 | Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men |
| Q44465381 | Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India |
| Q72025887 | Serum Concentration of Lp(a) in Patients with Primary Gout |
| Q72770958 | Serum LP(A) levels in randomized healthy men from different European countries |
| Q36846895 | Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery |
| Q43924594 | Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease |
| Q71625829 | Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis |
| Q24601964 | Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production |
Search more.